These three Pharma stocks should be on your radar today; Key factors explained

December 24, 2025
Uncategorized

While both Ajanta Pharma and Zydus Life inked licensing deals, Emcure Pharma’s unit has received an establishment inspection report (EIR) from the US Drug Regulator.

These three Pharma stocks should be on your radar today; Key factors explained

Leave a ReplyCancel Reply

Torrent Pharma shares in focus after steady Q3; Street positive on JB merger benefits

Why are gold and silver trading volatile despite softer dollar

Lupin shares may see up to 16% upside post Q3, analysts say — should you buy?

Netflix and Amazon are among the most oversold stocks on Wall Street

Angel One, Groww shares in focus after RBI tightens capital market exposure norms